sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 451-475 out of 1412.

<< < 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 > >>

Public Release: 20-Apr-2017
SIAM Journal on Applied Dynamical Systems
Periodic model predicts the spread of Lyme disease
Lyme disease is among the most common vector-borne illnesses in North America, Europe, and some parts of Asia. A spirochete bacterium called Borrelia burgdorferi causes the disease, and blacklegged ticks are responsible for the majority of North American transmissions. In a paper publishing next week in the SIAM Journal on Applied Dynamical Systems, Xiunan Wang and Xiao-Qiang Zhao present a mathematical model of Lyme disease that incorporates seasonality and climate factors.

Contact: Lina Sorg
sorg@siam.org
267-350-6371
Society for Industrial and Applied Mathematics

Public Release: 20-Apr-2017
PLOS Pathogens
On the brink of eradication: Why polio research matters
In the decades since Dr. Jonas Salk developed the first polio vaccine, cases of polio have exponentially declined. Though once widespread epidemic, the highly infectious childhood disease is now close to global eradication. The question remains: why would researchers spend time and resources studying a virus already on the brink of total eradication?

Contact: PLOS Pathogens
plospathogens@plos.org
PLOS

Public Release: 19-Apr-2017
Cell Host & Microbe
Defective HIV proviruses reduce effective immune system response, interfere with HIV cure
A new study finds defective HIV proviruses, long thought to be harmless, produce viral proteins and distract the immune system from killing intact proviruses needed to reduce the HIV reservoir and cure HIV. The study was published by researchers at the George Washington University and Johns Hopkins University in Cell Host & Microbe.
National Institutes for Health, amfAR generationCURE

Contact: Lisa Anderson
lisama2@gwu.edu
202-994-3121
George Washington University

Public Release: 19-Apr-2017
European Journal of Preventive Cardiology
Personalized workouts to prevent heart disease designed by new digital instrument
Personalized workouts to prevent heart disease can be designed by a new digital instrument, according to research published today in the European Journal of Preventive Cardiology. The EXPERT tool specifies the ideal exercise type, intensity, frequency, and duration needed to prevent a first or repeat cardiovascular event.
UHasselt IOF PoC project

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 19-Apr-2017
The Lancet
Widely disparate spending on health forecast through 2040
Spending on health care by nations is expected to increase significantly over the next two decades, but the rates of increase and sources of spending will differ widely, according to a new analysis.
Bill & Melinda Gates Foundation

Contact: Dean Owen
dean1227@uw.edu
206-434-5630
Institute for Health Metrics and Evaluation

Public Release: 19-Apr-2017
The International Liver CongressTM 2017
Journal of Hepatology
ILC 2017: Four new EASL clinical practice guidelines on the management of liver diseases
The European Association for the Study of the Liver (EASL) today announced that four new Clinical Practice Guidelines (CPGs) will be presented at The International Liver Congress™ 2017 in Amsterdam, The Netherlands, and published in the Journal of Hepatology, EASL's official journal. CPGs define the use of diagnostic, therapeutic and preventive modalities, including non-invasive and invasive procedures, in the management of patients with various liver diseases.

Contact: ILC press office
ilcpressoffice@ruderfinn.co.uk
44-078-410-09252
European Association for the Study of the Liver

Public Release: 18-Apr-2017
Nature Microbiology
Researchers identify tactic Dengue virus uses to delay triggering immune response
Mount Sinai researchers describe novel mechanism cells use to recognize earliest stages of infection and how virus evades triggering an immune response.

Contact: Lucia Lee
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine

Public Release: 18-Apr-2017
Innovate UK funds new kind of vaccine to target deadly pathogens emerging from animals
A team of international scientists led by Dr. Michael Jarvis at the University of Plymouth has received funding in excess of £408,000 from Innovate UK to develop a new and economic vaccine designed to halt the spread of highly pathogenic 'zoonotic' (spreading from animals to humans) infectious diseases.
Innovate UK

Contact: Andrew Gould
andrew.gould@plymouth.ac.uk
University of Plymouth

Public Release: 14-Apr-2017
Journal of Medical Entomology
Traces of Zika Found in Asian tiger mosquito in Brazil
In a recent test of Asian tiger mosquitoes collected in Brazil, researchers found fragments of Zika virus RNA, raising concerns that it may be carried by species other than Zika's known primary vector, the yellow fever mosquito. The research does not conclude that the Asian tiger mosquito (Aedes albopictus) can transmit Zika to humans, but it highlights the need for deeper research into additional potential vectors for the virus.
Florida Department of Agriculture and Consumer Services

Contact: Joe Rominiecki
jrominiecki@entsoc.org
301-731-4535 x3009
Entomological Society of America

Public Release: 13-Apr-2017
First large-scale survey of Chagas disease in the United States confirms that the 'silent killer' is a major public health challenge for the country
A study of almost 5,000 Latin American-born residents of Los Angeles County found that 1.24 percent tested positive for Chagas disease, a parasitic infection that can cause life-threatening heart damage if not treated early. Chagas disease is one of the leading causes of heart failure in Latin America.

Contact: Ilan Moss
imoss@dndi.org
646-266-5216
Drugs for Neglected Diseases Initiative

Public Release: 13-Apr-2017
PLOS Neglected Tropical Diseases
Drinking iced tea may boost cholera risk in endemic countries
After more than a decade of declining cholera incidence, Vietnam faced an increase in cases of the diarrheal disease during 2007-2010. Risk factors for contracting cholera in Ben Tre province of Vietnam include drinking iced tea or unboiled water and having a water source near a toilet, researchers report in PLOS Neglected Tropical Diseases.

Contact: PLOS Neglected Tropical Diseases
plosntds@plos.org
PLOS

Public Release: 12-Apr-2017
Analytical Sciences
On-the-range detection technology could corral bovine TB
A research breakthrough allowing the first direct, empirical, blood-based, cow-side test for diagnosing bovine tuberculosis (TB) could spare ranchers and the agriculture industry from costly quarantines and the mass slaughter of animals infected with this easily spread disease.
New Mexico Small Business Assistance, US Department of Agriculture, Los Alamos Research and Development Directed Research Program

Contact: Nancy Ambrosiano
nwa@lanl.gov
505-667-0471
DOE/Los Alamos National Laboratory

Public Release: 12-Apr-2017
Science Translational Medicine
NIH study of Ebola patient traces disease progression and recovery
Analysis of daily gene activation in a patient with severe Ebola virus disease cared for at NIH in 2015 found changes in antiviral and immune response genes that pinpointed key transition points in the response to infection. The changes included a marked decline in antiviral responses that correlated with clearance of virus from white blood cells. NIAID researchers led the study.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Anne O. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 12-Apr-2017
Emerging Infectious Diseases
Why treating animals may be important in fighting resurgent tropical disease
As the World Health Organization steps up its efforts to eradicate a once-rampant tropical disease, a University of Washington study suggests that monitoring, and potentially treating, the monkeys that co-exist with humans in affected parts of the world may be part of the global strategy.
NIH/National Institute of Allergy and Infectious Diseases, National Center for Research Resources, Defense Advanced Research Projects Agency

Contact: Kim Eckart
keckart@uw.edu
206-616-5847
University of Washington

Public Release: 12-Apr-2017
Science Translational Medicine
Tackling Ebola, from supportive care to vaccines in clinical development
A new study reports the first detailed description of the day-by-day immune responses observed during the course of a patient's progression through, and recovery from, Ebola virus disease (EVD). During the EVD outbreak that struck West Africa from 2013 to 2015, more than 28,000 infections were reported, with 11,310 confirmed fatalities.

Contact: Jeffery K. Taubenberger
taubenbergerj@niaid.nih.gov
301-761-6453
American Association for the Advancement of Science

Public Release: 12-Apr-2017
Nature
A big-picture look at the world's worst Ebola epidemic
An international effort to analyze the entire database of Ebola virus genomes from the 2013-2016 West African epidemic reveals insights into factors that sped or slowed the rampage and calls for using real-time sequencing and data-sharing to contain future viral disease outbreaks.
European Commission, National Institutes of Health, National Science Foundation, Bill and Melinda Gates Foundation, Wellcome Trust, Clinton Health Access Initiative, and others

Contact: Claire Hudson
crhudson@fredhutch.org
206-667-7365
Fred Hutchinson Cancer Research Center

Public Release: 12-Apr-2017
European Journal of Preventive Cardiology
Exercise associated with improved heart attack survival
Exercise is associated with improved survival after a heart attack, according to research published today in the European Journal of Preventive Cardiology. The chances of survival increased as the amount of exercise rose.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 11-Apr-2017
MDI Biological Laboratory to provide incubator space to Monoclonals Inc.
The MDI Biological Laboratory has announced that it will provide laboratory incubator space to Monoclonals Inc., a biomedical startup that will relocate to Maine from West Lawn, Pennsylvania, in May. Monoclonals Inc. makes novel monoclonal antibodies for use in the diagnosis of viral diseases. Monoclonal antibodies enable the development of rapid test kits that allow physicians to quickly diagnose these diseases. Such diagnostic tools are extremely important in the treatment of infectious diseases.

Contact: Stefanie Matteson
smatteso@mdibl.org
207-288-9880
Mount Desert Island Biological Laboratory

Public Release: 11-Apr-2017
Water Environment Research
CDC/WHO Ebola guidelines could put sewer workers at risk
Research from Drexel University and the University of Pittsburgh suggests that guidelines for safe disposal of liquid waste from patients being treated for the Ebola virus might not go far enough to protect water treatment workers from being exposed.

Contact: Britt Faulstick
bef29@drexel.edu
215-895-2617
Drexel University

Public Release: 11-Apr-2017
BMJ
Higher tobacco taxes needed to reduce smoking rates in South Asia, new analysis says
Higher taxes on tobacco could reduce consumption in South Asia by at least one-third and avoid 35-45 million premature deaths, concludes an analysis published today in The British Medical Journal.

Contact: Leslie Shepherd
ShepherdL@smh.ca
416-864-6094
St. Michael's Hospital

Public Release: 10-Apr-2017
DesignMedix's malaria drug to enter clinical trials with support from NIH
DesignMedix Inc., a drug development company targeting drug resistant infectious diseases, has entered into an agreement with the National Institutes of Health that will pave the way for first-in-human clinical trials of DesignMedix's malaria drug DM1157.

Contact: Sandra Shotwell
shotwell@designmedix.com
503-348-0855
Portland State University

Public Release: 10-Apr-2017
Nature Medicine
The first live-attenuated vaccine candidate completely protects against Zika infection
The first live-attenuated Zika vaccine still in the development stage completely protected mice against the virus after a single vaccination dose, according to new research from the University of Texas Medical Branch at Galveston and Instituto Evandro Chagas at the Ministry of Health in Brazil. The findings are currently available in Nature Medicine.

Contact: Donna Ramirez
donna.ramirez@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston

Public Release: 10-Apr-2017
Nature Communications
Researchers gain insight into protein critical to Zika virus reproduction
Berkeley Lab researchers collaborated with colleagues from the University of Indiana and Texas A&M University to solve the atomic structure of a Zika virus protein that is key to viral reproduction. The X-ray studies were conducted at the Advanced Light Source in the Berkeley Center for Structural Biology.
National Institutes of Health, Howard Hughes Medical Institute

Contact: Jon Weiner
jrweiner@lbl.gov
510-486-4014
DOE/Lawrence Berkeley National Laboratory

Public Release: 10-Apr-2017
Proceedings of the National Academy of Sciences
Vaccines save lives, but maintaining widespread coverage is essential
Emory Vaccine Center leaders emphasize vaccines' life-saving and economic benefits along with importance of community confidence in vaccination.

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory Health Sciences

Public Release: 10-Apr-2017
Proceedings of the National Academy of Sciences
El Nino shifts geographic distribution of cholera cases in Africa
Cholera cases in East Africa increase by roughly 50,000 during El Niño, the cyclical weather occurrence that profoundly changes global weather patterns, new Johns Hopkins Bloomberg School of Public Health research suggests.
Bill and Melinda Gates Foundation, National Science Foundation

Contact: Stephanie Desmon
sdesmon1@jhu.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health

Showing releases 451-475 out of 1412.

<< < 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 > >>